CRESTOR® (rosuvastatine calcique)

Crestor (rosuvastatine calcique) est une statine inhibitrice de l’HMG-CoA pour le traitement de la dyslipidémie et de l’hypercholestérolémie.

Références

  1. Crestor, Résumé des caractéristiques du produit, version la plus récente
  2. Guyton AC, Hall JE. Textbook of Medical Physiology [Manuel de Physiologie Médicale]. 11th ed. Philadelphia. PA: Elsevier Inc  2006.
  3. Lusis AJ. Atherosclerosis. Nature. 2000;407:233·241.
  4. National Heart, Lung and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ill): Final Report. Bethesda, MD: National Institutes of Health; 2002. NIH Publication 02·5215.
  5. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47 (suppl):C7·CI2.
  6. Informations de prescription pour CRESTOR. AstraZeneca Pharmaceuticals LP, Wilmington, DE.
  7. Informations de prescription pour Pravachol. Bristol-Myers Squibb Company. 
  8. Princeton, NJ, Quion JA, Jones PH. Clinical pharmacokinetics of pravastatin. Clin Pharmacokinet. 1994;27(2):94-103.
  9. Informations de prescription pour Lipitor. Pfizer Inc., New York, NY.
  10. Lennernas H. Clinical pharmacokinetics Of atorvastatin. Clin Pharmacokinet. 2003;42(13):1141-1160.
  11. Informations de prescription pour Zocor. Merck & Co., Whitehouse Station, NJ.
  12. Grundy SM. Ctecman Jt, Merz CNB, et al; for the Coordinating Committee of the National Cholesterol Education Proqram. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227·239.
  13. Karlson BW. Barter PJ, Palmer MK, et al. Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER. Nutr Metab Cardiovasc Dis. 2012;22(9):697·703.
  14. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Hurt Association Task Force on Practice Guidelines. J Am Coli Cardiol. (2013), doi: 10.1016/J.jacc.2013.11.002.
  15. Yusuf et al. N Eng J Med 2016 ; 374 : 2021-31
  16. Captano et al. Eur Heart J (2016) 37, 2999-3058
  17. Koenig et al. Eur Heart J 2011; 32:75-83

NS ID BE-1025-RD04/2018-WEB Local code 432